🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

GLOBAL MARKETS-Asian shares hit record high as U.S. stimulus seen within reach

Published 2020-12-03, 10:26 p/m
© Reuters.

* Ex-Japan Asia shares rises above Nov peak

* U.S. stock futures up, rebounding after Pfizer (NYSE:PFE) report hit

* Euro, emerging market currencies at highest since April 2018

* 2020 asset performance http://tmsnrt.rs/2yaDPgn

By Hideyuki Sano

TOKYO, Dec 4 (Reuters) - Asian shares scaled a record high on Friday on the growing prospect of a large U.S. economic package, while hopes that vaccine rollouts will boost the global economy underpinned investor sentiment.

MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS rose 0.6%, surpassing its Nov. 25 peak, while Japan's Nikkei .N225 dipped 0.4% on profit-taking.

In New York, the S&P 500 .SPX fell 0.06% on Thursday, erasing earlier gains after the Wall Street Journal reported that Pfizer PFE.N had slashed the target for the rollout of its COVID-19 vaccine due to supply chain obstacles. the damage did not last long, with S&P500 futures ESc1 gaining 0.3% in early Friday trade.

A bipartisan, $908 billion coronavirus aid plan gained momentum in the U.S. Congress on Thursday as conservative lawmakers expressed their support and Senate and House of Representatives leaders huddled. deal before the year-end looked almost impossible a while back but now a package of around $1 trillion seems within reach," said Norihiro Fujito, chief investment strategist at Mitsubishi UFJ Morgan Stanley (NYSE:MS) Securities.

On top of fiscal support, investors expect the U.S. Federal Reserve to tweak its guidance of its asset purchase scheme later this month while the European Central Bank looks certain to increase its bond buying next week.

Progress in developing COVID-19 vaccines also led investors to bet a recovery in corporate earnings will accelerate next year, overriding any concerns about the current dire conditions of the pandemic.

The United States topped 14 million known COVID-19 infections with over 100,000 patients hospitalized for the first time. California imposed stay-at-home orders to take effect when intensive care units approach capacity in the coming days. markets are behaving as if the world has already overcome the disease. In reality it will take time before vaccines will reach every corner of the world and infections start to decline," said Mitsubishi UFJ's Fujito.

"Given the rapid pace of gains in stock prices over the past month, there will be some profit-taking. Nevertheless, I don't think the market is peaking just yet."

The upbeat mood saw the U.S. dollar lose ground to other major currencies as well as riskier, less liquid ones.

The euro rose to $1.2142 EUR= , its highest levels since April 2018 while the yen stood at 103.85 per dollar JPY= , holding on to its 0.5% gains made the previous day.

The British pound changed hands at $1.3453 GBP=D4 , having hit a three-month high on Thursday with traders clinging to hopes of a trade deal between the European Union and Britain.

As talks continued to secure a Brexit deal, an EU official said an agreement was closer than ever but a UK government source warned chances for a breakthrough were receding. MSCI's emerging market currency index .MIEM00000CUS stood at 2 1/2-year high, having gained more than 10% from its March trough.

In commodities, oil prices got an additional lift after OPEC and Russia agreed to slightly ease their deep oil output cuts from January by 500,000 barrels per day (bpd) even as they failed to find a compromise on a broader and longer term policy. increase means the Organization of the Petroleum Exporting Countries and Russia, a group known as OPEC+, would move to cutting production by 7.2 million bpd, or 7% of global demand from January, compared with current cuts of 7.7 million bpd.

Brent crude rose to as high as $49.92 per barrel LCOc1 , its highest price since early March and last stood at $49.59.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ World FX rates in 2020

http://tmsnrt.rs/2egbfVh 2020 asset performance

http://tmsnrt.rs/2yaDPgn

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.